Exubera
Links shared publicly online about this topic
The IN VIVO Blog: Exubera: Fun with the Classics
invivoblog.blogspot.com — “The IN VIVO Blog: Exubera: Fun with the Classics” View full resource at invivoblog.blogspot.com
Most Recently Shared on December 6, 2010 at 3:20 am By:
Chris Morrison Health Communicator
Revisiting my favorite silly posts about Merck's Clark ( http://bit.ly/cvvpc7 ) and Pfizer's Kindler ( http://bit.ly/hN39KP )
Pharma Marketing Blog: Doctors (and Patients) were Smarter than Exubera Marketers
pharmamkting.blogspot.com — “Pharma Marketing Blog: Doctors (and Patients) were Smarter than Exubera Marketers” View full resource at pharmamkting.blogspot.com
Most Recently Shared on August 31, 2010 at 8:33 pm By:
Just published a comment frm anonymous who got my attention w/ ths opening: "John Mack, your (sic) an ASS." http://bit.ly/9nboHi
Dance Pharmaceuticals Gives Inhaled Insulin a --Do-Over-- (Exubera 3.0?) | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “Dance Pharmaceuticals Gives Inhaled Insulin a --Do-Over-- (Exubera 3.0?) | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on January 24, 2011 at 4:57 pm By:
Dance Pharmaceuticals Gives Inhaled Insulin a “Do-Over†(Exubera 3.0?): I can’t help it. This… http://goo.gl/fb/tC4Hi
PREVIEW-MannKind faces crucial test; many bet it will fail | Reuters
reuters.com — “* MannKind prepares for FDA ruling on insulin device * FDA set to rule on Afresa approval by Jan. 16 * Many on Wall St skeptical drug will be approved By Toni Clarke BOSTON, Jan 5 (Reuters) - MannKind” View full resource at reuters.com
Most Recently Shared on January 5, 2010 at 11:03 pm By:
Lisa Richwine Health Communicator
Will MannKind's inhaled insulin get past the "ghost of Exubera" to win FDA approval? Decision due Jan 16 http://link.reuters.com/fup89g
Is Inhaled Insulin Delivery Still A Possibility? Why Has It Been A Commercial Failure?
medicalnewstoday.com — “The commercial failure of Exubera® (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug d” View full resource at medicalnewstoday.com
Most Recently Shared on September 24, 2009 at 4:42 pm By:
Is Inhaled Insulin Delivery Still A Possibility? Why Has It Been A Commercial Failure?: The commercial failure o.. http://bit.ly/z5aaH
Is Inhaled Insulin Delivery Still a Possibility? Why Has it Been a Commercial Failure? : Is Inhaled Insulin Delivery Still a Possibility? Why Has it Been a Commercial Failure?
dlife.com — “Is Inhaled Insulin Delivery Still a Possibility? Why Has it Been a Commercial Failure? : Is Inhaled Insulin Delivery Still a Possibility? Why Has it Been a Commercial Failure?” View full resource at dlife.com
Most Recently Shared on September 23, 2009 at 7:28 pm By:
RT @diabetesblogs: Is Inhaled Insulin Delivery Still a Possibility? Why Has it Been a Commercial Failure? http://bit.ly/4kcKM9 #dblog
MannKind Updates Status of New Drug Application | Business Wire
businesswire.com — “VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq:MNKD) announced that it was informed today by the Food and Drug Administration that the FDA will not be able to complete the review of MannKind’s new drug application (NDA) for its ultra rapid-acting insulin therapy by the action date of January 16, 2010. The FDA explained that it has not yet completed its inspection of the insulin manufacturing facilities of N.V. Organon, a third-party supplier to MannKind. Organon is a subsi” View full resource at businesswire.com
Most Recently Shared on January 8, 2010 at 11:17 pm By:
Lisa Jarvis Science Enthusiast
Mannkind's inhaled insulin review pushed on Organon man delay. Too bad they lost out insulin at Pfizer's Exubera site. http://bit.ly/67qgOB
Home | InPharm
inpharm.com — “Home | InPharm” View full resource at inpharm.com
Most Recently Shared on February 11, 2009 at 2:30 pm By:
Pharmafocus Health News and Pharma
More on Viehbacher’s plans, including boosting non-Rx business and focusing on emerging markets. http://tinyurl.com/d25da9
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Chris Morrison
Editor w/ Elsevier Business Intelligence (f.k.a. Windhover/FDC Reports) family of publications
-
John Mack
Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News
-
Aimee Greenholtz
Diabetes Care. Helping people with diabetes succeed in leading a healthy life.
Advertisement
